260 related articles for article (PubMed ID: 29630986)
1. Camptothecin-loaded fusogenic nanodroplets as ultrasound theranostic agent in stem cell-mediated drug-delivery system.
Ho YJ; Chiang YJ; Kang ST; Fan CH; Yeh CK
J Control Release; 2018 May; 278():100-109. PubMed ID: 29630986
[TBL] [Abstract][Full Text] [Related]
2. Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
Chen WT; Kang ST; Lin JL; Wang CH; Chen RC; Yeh CK
Biomaterials; 2015; 53():699-708. PubMed ID: 25890765
[TBL] [Abstract][Full Text] [Related]
3. Concurrent anti-vascular therapy and chemotherapy in solid tumors using drug-loaded acoustic nanodroplet vaporization.
Ho YJ; Yeh CK
Acta Biomater; 2017 Feb; 49():472-485. PubMed ID: 27836803
[TBL] [Abstract][Full Text] [Related]
4. Theranostic Performance of Acoustic Nanodroplet Vaporization-Generated Bubbles in Tumor Intertissue.
Ho YJ; Yeh CK
Theranostics; 2017; 7(6):1477-1488. PubMed ID: 28529631
[TBL] [Abstract][Full Text] [Related]
5. Novel alginate-stabilized doxorubicin-loaded nanodroplets for ultrasounic theranosis of breast cancer.
Baghbani F; Moztarzadeh F; Mohandesi JA; Yazdian F; Mokhtari-Dizaji M
Int J Biol Macromol; 2016 Dec; 93(Pt A):512-519. PubMed ID: 27601134
[TBL] [Abstract][Full Text] [Related]
6. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
7. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin.
Yu H; Chen J; Liu S; Lu Q; He J; Zhou Z; Hu Y
J Control Release; 2015 Oct; 216():111-20. PubMed ID: 26282096
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model.
Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538
[TBL] [Abstract][Full Text] [Related]
9. Novel ultrasound-responsive chitosan/perfluorohexane nanodroplets for image-guided smart delivery of an anticancer agent: Curcumin.
Baghbani F; Chegeni M; Moztarzadeh F; Hadian-Ghazvini S; Raz M
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():186-193. PubMed ID: 28254284
[TBL] [Abstract][Full Text] [Related]
10. Stealth and non-stealth nanocapsules containing camptothecin: in-vitro and in-vivo activity on B16-F10 melanoma.
Loch-Neckel G; Nemen D; Puhl AC; Fernandes D; Stimamiglio MA; Alvarez Silva M; Hangai M; Santos Silva MC; Lemos-Senna E
J Pharm Pharmacol; 2007 Oct; 59(10):1359-64. PubMed ID: 17910810
[TBL] [Abstract][Full Text] [Related]
11. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
12. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of PLGA microspheres as delivery system for antitumor agent-camptothecin.
Tong W; Wang L; D'Souza MJ
Drug Dev Ind Pharm; 2003 Aug; 29(7):745-56. PubMed ID: 12906332
[TBL] [Abstract][Full Text] [Related]
14. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
15. Acoustic droplet vaporization in biology and medicine.
Lin CY; Pitt WG
Biomed Res Int; 2013; 2013():404361. PubMed ID: 24350267
[TBL] [Abstract][Full Text] [Related]
16. Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma.
Householder KT; DiPerna DM; Chung EP; Wohlleb GM; Dhruv HD; Berens ME; Sirianni RW
Int J Pharm; 2015 Feb; 479(2):374-80. PubMed ID: 25562639
[TBL] [Abstract][Full Text] [Related]
17. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
Tian H; Huang Y; He J; Zhang M; Ni P
ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound triggered phase-change nanodroplets for doxorubicin prodrug delivery and ultrasound diagnosis: An in vitro study.
Gao J; Yu B; Li C; Xu M; Cao Z; Xie X; Wang W; Liu J
Colloids Surf B Biointerfaces; 2019 Feb; 174():416-425. PubMed ID: 30481702
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-responsive nanobubbles contained with peptide-camptothecin conjugates for targeted drug delivery.
Xie X; Lin W; Liu H; Deng J; Chen Y; Liu H; Fu X; Yang Y
Drug Deliv; 2016 Oct; 23(8):2756-2764. PubMed ID: 26289216
[TBL] [Abstract][Full Text] [Related]
20. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.
Wang Y; Sui G; Teng D; Wang Q; Qu J; Zhu L; Ran H; Wang Z; Jin C; Wang H
Biomater Sci; 2018 Dec; 7(1):196-210. PubMed ID: 30422139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
